Weight regain after discontinuation: difference between revisions
Diff·revision 17 → 18·12:10, 6 Jun 2025
Difference between revision 17 and revision 18 of Weight regain after discontinuation. 5 lines changed; the page grew by 576 bytes.
| Revision 17 — 08:58, 18 May 2025 Areapercent_Ayo (talk) state that the frequency category follows the labelling convention 4,048 bytes +17 | Revision 18 — 12:10, 6 Jun 2025 NAION_Noel (talk) add the citation for the gallbladder finding 4,624 bytes +576 | ||
|---|---|---|---|
| 29 | What the trials do establish is that any decision about duration must be made in the knowledge that the effect is contingent on continued exposure. This wiki gives no advice on such decisions.{{r|ada2024}} | 29 | What the trials do establish is that any decision about duration must be made in the knowledge that the effect is contingent on continued exposure. This wiki gives no advice on such decisions.{{r|ada2024}} |
| 30 | 30 | ||
| + | 31 | == Related considerations == | |
| + | 32 | Because the agents have long half-lives, exposure persists for weeks after the last dose, and regain begins from the point at which concentrations fall below effect rather than from the day of the last injection. See [[Missed dose]].{{r|drucker2018}} | |
| + | 33 | ||
| + | 34 | Lean and fat mass regain in different proportions from those in which they were lost, with fat mass typically regained preferentially — a pattern documented across weight-loss modalities and not specific to this class. See [[Body composition assessment]] and [[Sarcopenia]].{{r|wilding2021}} | |
| + | 35 | ||
| 31 | == References == | 36 | == References == |
| 32 | {{reflist}} | 37 | {{reflist}} |